BPC-157: The Complete Guide to Body Protection Compound for Healing, Gut Health & Recovery

BPC-157 — short for Body Protection Compound 157 — is a synthetic pentadecapeptide (a chain of 15 amino acids) derived from a protein found naturally in human gastric juice. Originally isolated and studied for its remarkable gastrointestinal healing properties, BPC-157 has since become one of the most widely researched peptides in regenerative medicine, with a growing body of evidence supporting its role in tendon and ligament repair, muscle recovery, neuroprotection, and systemic anti-inflammatory action.

In this complete guide, we cover everything you need to know: what BPC-157 is, how it works mechanically, the peer-reviewed evidence behind its benefits, how to use it, and where to source pharmaceutical-grade BPC-157 in the UK.

What is BPC-157?

BPC-157 is a partial sequence of Body Protection Compound — a naturally occurring protein found in human gastric juice. The synthetic version (comprising 15 amino acids) was first characterised by Croatian researcher Dr Predrag Sikiric and his team at the University of Zagreb, who have published over 300 peer-reviewed papers on its properties over the past three decades.

Unlike many peptides that degrade rapidly in the gastrointestinal tract, BPC-157 has demonstrated notable stability in human gastric juice, making it effective via oral, subcutaneous, and intramuscular routes. It is not currently approved as a pharmaceutical drug, but is widely used in research and by clinicians operating in the peptide therapy space.

How Does BPC-157 Work?

BPC-157 exerts its effects through several interconnected biological mechanisms:

Angiogenesis promotion: BPC-157 upregulates VEGF (Vascular Endothelial Growth Factor) and promotes the formation of new blood vessels. Improved vascularisation accelerates the delivery of nutrients and oxygen to damaged tissues — a critical factor in tendon, ligament and muscle repair.
Nitric oxide modulation: BPC-157 activates the nitric oxide (NO) pathway, which plays a central role in blood flow regulation, inflammation control, and tissue repair. This mechanism is thought to underpin many of its systemic healing effects.
Growth hormone receptor sensitisation: Research indicates BPC-157 interacts with growth hormone receptors and may potentiate the healing effects of endogenous GH — without directly raising GH levels, avoiding associated side effects.
Tendon fibroblast activation: BPC-157 directly stimulates tendon fibroblasts (the cells responsible for producing collagen and extracellular matrix in tendons) to proliferate and migrate to sites of injury, significantly accelerating tendon healing.
Gut barrier repair: In the gastrointestinal tract, BPC-157 promotes the repair of the intestinal epithelium, reduces inflammation via the NF-κB pathway, and supports healthy mucus layer production — mechanisms that make it particularly effective for inflammatory bowel conditions.
Dopaminergic and serotonergic modulation: BPC-157 has demonstrated the ability to modulate both dopamine and serotonin systems in animal models, with implications for mood regulation and neuroprotection.

BPC-157 for Injury Recovery & Tissue Healing

The most extensively documented application of BPC-157 is accelerated healing of musculoskeletal injuries. Animal studies — predominantly in rats — have demonstrated:

Tendon healing: Multiple studies show BPC-157 significantly accelerates the healing of ruptured tendons, including Achilles tendon transections. Treated animals showed faster collagen remodelling, improved tensile strength, and superior functional recovery compared to controls.
Ligament repair: Studies on medial collateral ligament (MCL) injuries demonstrate faster healing and improved structural integrity in BPC-157 treated subjects — of particular interest to athletes recovering from knee and ankle injuries.
Muscle healing: BPC-157 has been shown to accelerate the repair of crushed muscle tissue and surgical muscle injuries, with treated subjects demonstrating faster functional recovery.
Bone healing: Research indicates BPC-157 may accelerate bone fracture healing by promoting osteoblast activity and vascularisation at fracture sites.
Wound healing: Topical and systemic BPC-157 has demonstrated accelerated closure of skin wounds, burns, and surgical incisions in multiple animal models.

While human clinical trials remain limited, the mechanistic evidence and extensive animal research have made BPC-157 a popular tool among athletes, biohackers, and clinicians managing sports injuries and post-surgical recovery.

BPC-157 for Gut Health & Inflammatory Bowel Conditions

BPC-157 was originally studied for gastrointestinal applications, and the evidence here is among the most robust in the literature:

Inflammatory Bowel Disease (IBD): Studies in animal models of Crohn's disease and ulcerative colitis show BPC-157 significantly reduces intestinal inflammation, promotes mucosal healing, and restores gut barrier integrity.
Leaky gut / intestinal permeability: BPC-157 repairs tight junctions between intestinal epithelial cells, reducing the permeability that underlies "leaky gut" and associated systemic inflammation.
Gastric ulcers: BPC-157 was originally characterised as an anti-ulcer peptide. It promotes healing of NSAID-induced, alcohol-induced, and stress-induced gastric ulcers at remarkable speed in animal models.
GERD and oesophageal damage: Research shows BPC-157 heals oesophageal lesions and reduces acid reflux-related damage, suggesting potential applications in GERD management.
IBS: The gut-brain axis effects of BPC-157 (via serotonin modulation) may also benefit IBS patients, though this area requires further human research.

BPC-157 for Neuroprotection & Brain Health

An increasingly researched area is BPC-157's neuroprotective properties:

Traumatic brain injury (TBI): Animal studies show BPC-157 reduces brain lesion size and improves functional recovery following TBI, through promotion of angiogenesis and reduction of neuroinflammation.
Parkinson's model protection: BPC-157 has demonstrated protective effects in dopaminergic neurons in animal models of Parkinson's disease, suggesting potential neuroprotective applications.
Peripheral nerve repair: Studies show BPC-157 accelerates functional recovery following peripheral nerve crush injuries, relevant to post-surgical nerve damage rehabilitation.
Depression and anxiety models: BPC-157 has shown anxiolytic and antidepressant-like effects in animal models, thought to be mediated through its modulation of dopamine and serotonin systems.

BPC-157 for Cardiovascular Health

BPC-157's nitric oxide modulating effects extend to the cardiovascular system:

Studies show BPC-157 can counteract the cardiovascular toxicity induced by certain drugs (including some NSAIDs and corticosteroids)
It has demonstrated protective effects on heart tissue following induced ischaemia
BPC-157 may support healthy blood pressure regulation through its NO pathway effects

BPC-157 Dosing & Protocols

Dosing in research contexts varies by application and route of administration. The most common protocols used in research settings are:

Subcutaneous injection: 200–500 mcg per day, injected near the site of injury or systemically. This is the most common research protocol for musculoskeletal injuries.
Intramuscular injection: Similar dosing to subcutaneous, used when targeting deeper muscle tissue.
Oral / capsule: 250–500 mcg per day. Oral BPC-157 is considered primarily effective for gastrointestinal applications, given that it acts locally on gut tissue before systemic absorption.

Typical research cycles run 4–12 weeks depending on the condition being studied. BPC-157 does not require post-cycle therapy (PCT) as it does not affect the hypothalamic-pituitary axis.

Note: As with all research peptides, consult with a qualified healthcare professional before use. The protocols above are for informational and research reference purposes only.

BPC-157 Safety Profile

BPC-157 has a highly favourable safety profile across decades of animal research:

No LD50 (lethal dose) has been established in animal studies — even at extremely high doses, no fatalities were observed
No significant organ toxicity has been identified in studies to date
BPC-157 does not appear to stimulate tumour growth (unlike some growth factors)
No hormonal suppression or disruption of the HPA/HPG axis
Mild injection site reactions (redness, swelling) are occasionally reported, typically resolving within hours

While long-term human clinical trial data is still limited, the existing research profile makes BPC-157 one of the safer peptides currently under investigation.

Where to Buy BPC-157 in the UK

Sourcing quality BPC-157 is critical — purity, sterility and accurate dosing all depend on the manufacturer. Altheabio supplies pharmaceutical-grade BPC-157 with every batch independently third-party tested for purity and heavy metal content. Certificates of Analysis are available on our lab reports page.

We offer fast UK dispatch, discreet packaging, and full reconstitution guidance with every order.

BPC-157: Key Takeaways

BPC-157 is a 15-amino acid peptide derived from human gastric juice with over 300 published studies supporting its healing properties
It works primarily through angiogenesis promotion, nitric oxide modulation, and direct fibroblast activation
Most extensively evidenced for tendon/ligament repair, gut healing (IBD, ulcers, leaky gut), and muscle recovery
Emerging evidence supports neuroprotective and cardiovascular protective effects
Excellent safety profile — no LD50 established, no hormonal suppression, no identified organ toxicity
Available via subcutaneous injection (systemic/injury-site) or oral capsule (gut-specific applications)
Source pharmaceutical-grade, third-party tested BPC-157 from a reputable UK supplier for research use